Breaking News
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Innovative strategy opens up new avenue of treatment for anthrax infections
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
Researchers develop personalized and low-cost wearable UV sensors

Researchers develop personalized and low-cost wearable UV sensors

image_pdfDownload PDFimage_print

Researchers from the University of Granada and RMIT University in Melbourne have developed personalized and low-cost wearable ultraviolet (UV) sensors that warn users when their exposure to the sun has become dangerous.

The paper-based sensor, which can be worn as a wristband, features happy and sad emoticon faces—drawn in an invisible UV-sensitive ink—that successively light up as you reach 25%, 50%, 75% and finally 100% of your daily recommended UV exposure.

The research team have also created six versions of the color-changing wristbands, each of which is personalized for a specific skin tone — an important characteristic given that darker people need more sun exposure to produce vitamin D, which is essential for healthy bones, teeth and muscles.

The groundbreaking research findings were published last week in the prestigious international journal Nature Communications.

Skin cancer, one of the most common types of cancer throughout the world, is primarily caused by overexposure to ultraviolet radiation (UVR). In Spain, over 74,000 people are diagnosed with non-melanoma skin cancer every year, while a further 4,000 are diagnosed with melanoma skin cancer. In regions such as Australia, where the ozone layer has been substantially depleted, it is estimated that approximately 2 in 3 people will be diagnosed with skin cancer by the time they reach the age of 70.

“UVB and UVC radiation is retained by the ozone layer. This sensor is especially important in the current context, given that the hole in the ozone layer is exposing us to such dangerous radiation”, explains José Manuel Domínguez Vera, a researcher at the University of Granada’s Department of Inorganic Chemistry and the main author of the paper.

Domínguez Vera also highlights that other sensors currently available on the market only measure overall UV radiation, without distinguishing between UVA, UVB and UVC,each of which has a significantly different impact on human health. In contrast, the new paper-based sensor can differentiate between UVA, UVB and UVC radiation. Prolonged exposure to UVA radiation is associated with skin aging and wrinkling, while excessive exposure to UVB causes sunburn and increases the likelihood of skin cancer and eye damage.

Drawbacks of the traditional UV index

Ultraviolet radiation is determined by aspects such as location, time of day, pollution levels, astronomical factors, weather conditions such as clouds, and can be heightened by reflective surfaces like bodies of water, sand and snow. But UV rays are not visible to the human eye (even if it is cloudy UV radiation can be high) and until now the only way of monitoring UV intensity has been to use the UV index, which is standardly given in weather reports and indicates 5 degrees of radiation; low, moderate, high, very high or extreme.

Despite its usefulness, the UV index is a relatively limited tool. For instance, it does not clearly indicate what time of the day or for how long you should be outside to get your essential vitamin D dose, or when to cover up to avoid sunburn and a heightened risk of skin cancer.

Moreover, the UV index is normally based on calculations for fair skin, making it unsuitable for ethnically diverse populations. While individuals with fairer skin are more susceptible to UV damage, those with darker skin require much longer periods in the sun in order to absorb healthy amounts of vitamin D. In this regard, the UV index is not an accurate tool for gauging and monitoring an individual’s recommended daily exposure.

UV-sensitive ink

The research team set out to tackle the drawbacks of the traditional UV index by developing an inexpensive, disposable and personalised sensor that allows the wearer to track their UV exposure in real-time. The sensor paper they created features a special ink, containing phosphomolybdic acid (PMA), which turns from colourless to blue when exposed to UV radiation. They can use the initially-invisible ink to draw faces—or any other design—on paper and other surfaces. Depending on the type and intensity of the UV radiation to which the ink is exposed, the paper begins to turn blue; the greater the exposure to UV radiation, the faster the paper turns blue.

Additionally, by tweaking the ink composition and the sensor design, the team were able to make the ink change color faster or slower, allowing them to produce different sensors that are tailored to the six different types of skin color.

Applications beyond health

This low-cost, paper-based sensor technology will not only help people of all colors to strike an optimum balance between absorbing enough vitamin D and avoiding sun damage — it also has significant applications for the agricultural and industrial sectors. UV rays affect the growth of crops and the shelf life of a range of consumer products. As the UV sensors can detect even the slightest doses of UV radiation, as well as the most extreme, this new technology could have vast potential for industries and companies seeking to evaluate the prolonged impact of UV exposure on products that are cultivated or kept outdoors.

Source:

https://canal.ugr.es/noticia/new-wristband-real-time-tracking-uv-exposure/

Tagged with:

About author

Related Articles